NCT04546308View on ClinicalTrials.gov

Central Arterial Hemodynamics and Resistance Training

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 21, 2019

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
HypertensionCardiovascular Risk Factor
Interventions
OTHER

Resistance exercise training

Eight weeks whole-body resistance exercise training (80%1 repetition maximal, 3 sessions per week) followed by a 4-week detraining intervention

Trial Locations (1)

106

National Taiwan University, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT04546308 - Central Arterial Hemodynamics and Resistance Training | Biotech Hunter | Biotech Hunter